Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes
Conclusions
Long term immunosuppression with tacrolimus, azathioprine and short term prednisolone in HCV cirrhosis recipients resulted in slower progression to severe fibrosis assessed by Ishak stage and CPA, less portal hypertension and decompensation, compared with tacrolimus alone.
ISRCTN94834276
—Randomised study for immunosuppression regimen in liver transplantation.
Source: Gut - Category: Gastroenterology Authors: Manousou, P., Cholongitas, E., Samonakis, D., Tsochatzis, E., Corbani, A., Dhillon, A. P., Davidson, J., Rodriguez-Peralvarez, M., Patch, D., O'Beirne, J., Thorburn, D., Luong, T., Rolles, K., Davidson, B., McCormick, P. A., Hayes, P., Burroughs, A. K. Tags: Open access Hepatology Source Type: research
More News: Bleeding | Cirrhosis | Gastroenterology | Hepatitis | Hypertension | Liver | Liver Transplant | Prednisolone | Prograf | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology